Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia
Clinical trial NCT01198067 · TERMINATED
Trial details
- NCT number
- NCT01198067
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-06
- Primary completion
- 2025-05-02
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.